[Skip to Content]

Upstate Active Clinical Trials

Study Title:

ALTE03N1 - Key Adverse Events Following Childhood Cancer

What is the purpose of the study? (in Layman's terms, please describe the study)

Study to identify subjects who are more likely to develop late-occurring complications. Identified subjects are observed closely in order to prevent complications from occurring or to find complications early.

Upstate Institutional Review Board (IRB) Number:

264681

Study/Protocol ID:

ALTE03N1

Study Phase:

N/A

Patient Age Group:

Children

Principal Investigator:

Philip Monteleone

ClinicalTrials.Gov ID:

NCT00082745

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Karen B Bilynsky
Phone: 315-464-7601
Email: bilynskk@upstate.edu

Return to Previous Page || Search Again

Top